Frexalimab

Modify Date: 2024-09-17 22:16:13

Frexalimab Structure
Frexalimab structure
Common Name Frexalimab
CAS Number 2515463-86-0 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Frexalimab


Frexalimab (SAR441344; INX-021) is a monoclonal antibody targeting the CD40 ligand (CD40L). Frexalimab has the potential for multiple sclerosis research[1].

 Names

Name Frexalimab

 Frexalimab Biological Activity

Description Frexalimab (SAR441344; INX-021) is a monoclonal antibody targeting the CD40 ligand (CD40L). Frexalimab has the potential for multiple sclerosis research[1].
Related Catalog
References

[1]. Bruce A C Cree, et al. New drugs for multiple sclerosis: new treatment algorithms. Curr Opin Neurol. 2022 Jun 1;35(3):262-270.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties